Benefits:
- Saves time with fast analyses and easy to use, intuitive workflows
- Offers validated, reproducible results that you can rely on
- Accurate lumen and reference measurements in vessel analyses support device and treatment selection
- QAngio XA in combination with DataConvert cuts down drastically the time required for image analysis and data processing
NEW in QAngio XA 7.3:
- A complete new look with new icons and a tabular wizard for easy and fast navigation through the analysis workflow
- Drag and drop images for simple and fast selection of analysis acquisitions
- Isocenter calibration, reducing analysis time and observer variability
- Display of most important analysis results on the image
- T-shape and Y-shape bifurcation analysis now include angle measurements
- Analysis of right ventriculograms
Features of QCA and QVA
(coronary and peripheral vessel analysis)
- Automatic analysis of straight, ostial and bifurcated segments
- Fast, two-click and three-click automatic pathline detection and superb, proven automatic contour detection
- Analysis of straight vessel segments treated with (drug eluting) stents or vascular brachy therapy
- Sub-segment and edge-segment analyses
- Innovative bifurcation analysis models (Y-shape and T-shape)
- Analysis of standard digital, subtracted and inverted images
- ECG visualization
- Very simple and intuitive contour correction options
- Isocenter calibration
Features of QLV and QRV
(left and right ventricular analysis)
- Analysis of left and right ventriculograms
- Automatic left ventricular contour detection
- Calculation of global and regional ejection fraction in left ventriculograms
- Three wall-motion reference models: Centerline, Stanford, and Slager
All Modules
- Audit-trailing to safeguard standard working procedures
- DataConvert™ for conversion of analysis results to various formats, including HTML and Microsoft® Excel® XML, cutting down the time required for data processing drastically
‘QAngio XA has proven to be very intuitive and easy to learn, even with the challenging cases in our large real-world population trial.
It allows us to perform a high volume of quantitative angiographic analyses with limited personnel.’






